CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,200 | -37.0% | 14,000 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $51,100 | +2.2% | 14,000 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $49,980 | +25.3% | 14,000 | 0.0% | 0.01% | +16.7% |
| Q4 2022 | $39,900 | +10.8% | 14,000 | -12.5% | 0.01% | +20.0% |
| Q3 2022 | $36,000 | -10.0% | 16,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $40,000 | -48.7% | 16,000 | 0.0% | 0.01% | -44.4% |
| Q1 2022 | $78,000 | -56.9% | 16,000 | 0.0% | 0.01% | -55.0% |
| Q4 2021 | $181,000 | -37.8% | 16,000 | -20.0% | 0.02% | -42.9% |
| Q3 2021 | $291,000 | +24.9% | 20,000 | 0.0% | 0.04% | +25.0% |
| Q2 2021 | $233,000 | -4.5% | 20,000 | 0.0% | 0.03% | -12.5% |
| Q1 2021 | $244,000 | -2.4% | 20,000 | 0.0% | 0.03% | -8.6% |
| Q4 2020 | $250,000 | – | 20,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 948,389 | $13,818,000 | 26.68% |
| Prosight Management, LP | 655,185 | $9,546,000 | 5.25% |
| P.A.W. CAPITAL CORP | 125,000 | $1,821,000 | 1.62% |
| Nantahala Capital Management | 2,571,082 | $37,461,000 | 1.18% |
| Slate Path Capital LP | 1,483,619 | $21,616,000 | 0.99% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $6,971,000 | 0.79% |
| SANDERS MORRIS HARRIS LLC | 305,732 | $4,103,000 | 0.75% |
| APOGEM CAPITAL LLC | 51,766 | $754,000 | 0.48% |
| 683 Capital Management, LLC | 743,772 | $10,837,000 | 0.42% |
| Bleichroeder LP | 175,000 | $2,550,000 | 0.41% |